Genolution Inc. (225220) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, Genolution Inc. (225220) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-927.21 Million ≈ $-628.35K USD) by net assets (₩73.39 Billion ≈ $49.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Genolution Inc. fund operations to measure how many days the company can operate on defensive assets alone.

Genolution Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Genolution Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genolution Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genolution Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
IRIDEX Corporation NASDAQ:IRIX	0.120x
Paragon Banking Group PLC LSE:PAG	-0.465x
MMC Sanayi ve Ticari Yatirimlar AS IS:MMCAS	0.001x
Nexen Tire Prf 1 KO:002355	0.034x
Benalec Holdings Bhd KLSE:5190	0.004x
Core AI Holdings NASDAQ:CHAI	N/A
FACILITIES BY ADF LS-01 F:ZC8	N/A
Neometals Ltd AU:NMT	-0.236x

Annual Cash Flow Conversion Efficiency for Genolution Inc. (2016–2024)

The table below shows the annual cash flow conversion efficiency of Genolution Inc. from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Genolution Inc..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩80.29 Billion ≈ $54.41 Million	₩-1.43 Billion ≈ $-970.93K	-0.018x	-37.43%
2023-12-31	₩87.45 Billion ≈ $59.26 Million	₩-1.14 Billion ≈ $-769.54K	-0.013x	-109.07%
2022-12-31	₩94.70 Billion ≈ $64.18 Million	₩13.55 Billion ≈ $9.18 Million	0.143x	-54.29%
2021-12-31	₩82.20 Billion ≈ $55.71 Million	₩25.73 Billion ≈ $17.44 Million	0.313x	-58.26%
2020-12-31	₩61.29 Billion ≈ $41.54 Million	₩45.97 Billion ≈ $31.15 Million	0.750x	+2556.06%
2019-12-31	₩2.64 Billion ≈ $1.79 Million	₩-80.58 Million ≈ $-54.61K	-0.031x	-160.85%
2018-12-31	₩2.94 Billion ≈ $1.99 Million	₩147.49 Million ≈ $99.95K	0.050x	-72.00%
2017-12-31	₩4.00 Billion ≈ $2.71 Million	₩717.13 Million ≈ $485.99K	0.179x	+2372.91%
2016-12-31	₩3.42 Billion ≈ $2.32 Million	₩-27.00 Million ≈ $-18.30K	-0.008x	--

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$17.91 Million

₩26.43 Billion KRW

Market Cap Rank

#25484 Global

#1848 in Korea

Share Price

₩1463.00

Change (1 day)

-0.41%

52-Week Range

₩1440.00 - ₩2590.00

All Time High

₩10300.23